New chronic inflammatory demyelinating polyneuropathy/Guillain-Barré syndrome guidelines – impact on clinical practise
Curr Opin Neurol. 2024 Jun 17. doi: 10.1097/WCO.0000000000001290. Online ahead of print. ABSTRACT PURPOSE OF REVIEW: There is no diagnostic biomarker that can reliably detect …